SYNI — Synvista Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$7.96m
- $0.05m
Annual cashflow statement for Synvista Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.5 | -14 | -12.6 | -17.7 | -16.1 |
| Depreciation | |||||
| Non-Cash Items | 0.051 | -0.017 | 0.027 | 11.5 | 7.06 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.01 | 0.791 | -1.51 | -1.28 | 1.07 |
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -15.9 | -13.1 | -14 | -7.44 | -7.95 |
| Capital Expenditures | -0.086 | -0.081 | -0.013 | 0 | -0.017 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.73 | 0.102 | -0.079 | -1.47 | -0.4 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.65 | 0.021 | -0.092 | -1.47 | -0.417 |
| Financing Cash Flow Items | — | — | — | 0 | -2.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.5 | 7.59 | 9.53 | 3.81 | 22.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.23 | -5.5 | -4.59 | -5.1 | 14.2 |